Does the media refer more to SPAI or KIDS?

In the previous week, Safe Pro Group had 6 more articles in the media than OrthoPediatrics. MarketBeat recorded 9 mentions for Safe Pro Group and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.63 beat Safe Pro Group's score of 0.43 indicating that OrthoPediatrics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Safe Pro Group 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to DCTH or SPAI?

In the previous week, Safe Pro Group had 7 more articles in the media than Delcath Systems. MarketBeat recorded 9 mentions for Safe Pro Group and 2 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.94 beat Safe Pro Group's score of 0.43 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Safe Pro Group 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

Do analysts recommend CNXU or SPAI?

Safe Pro Group has a consensus price target of $10.00, indicating a potential upside of 91.94%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts plainly believe Safe Pro Group is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Safe Pro Group 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 2.80

Which has better earnings and valuation, CNXU or SPAI?

Conexeu Sciences has higher earnings, but lower revenue than Safe Pro Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Safe Pro Group $610K 178.42 -$14.32M -$0.71 N/A

Does the media prefer CNXU or SPAI?

In the previous week, Safe Pro Group had 6 more articles in the media than Conexeu Sciences. MarketBeat recorded 9 mentions for Safe Pro Group and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.44 beat Safe Pro Group's score of 0.43 indicating that Conexeu Sciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Safe Pro Group 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral

Is SPAI or CV more profitable?

CapsoVision has a net margin of -198.87% compared to Safe Pro Group's net margin of -800.91%. CapsoVision's return on equity of 0.00% beat Safe Pro Group's return on equity. Company Net Margins Return on Equity Return on Assets Safe Pro Group -800.91% -119.17% -107.17% CapsoVision -198.87% N/A -136.03%

Does the media prefer SPAI or CV?

In the previous week, Safe Pro Group had 7 more articles in the media than CapsoVision. MarketBeat recorded 9 mentions for Safe Pro Group and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.32 beat Safe Pro Group's score of 0.43 indicating that CapsoVision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Safe Pro Group 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Neutral CapsoVision 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Safe Pro Group (SPAI) Competitors

$5.21 +0.09 (+1.76%)

As of 12:01 PM Eastern

Compare

SPAI vs. KIDS, CLPT, DCTH, CNXU, and CV

Should you buy Safe Pro Group stock or one of its competitors? MarketBeat compares Safe Pro Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Safe Pro Group include OrthoPediatrics (KIDS), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Conexeu Sciences (CNXU), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Safe Pro Group compare to OrthoPediatrics?

Safe Pro Group (NASDAQ:SPAI) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment and earnings.

Safe Pro Group has a beta of 3.28, suggesting that its share price is 228% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, suggesting that its share price is 3% more volatile than the broader market.

In the previous week, Safe Pro Group had 6 more articles in the media than OrthoPediatrics. MarketBeat recorded 9 mentions for Safe Pro Group and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.63 beat Safe Pro Group's score of 0.43 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Safe Pro Group	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Safe Pro Group has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Safe Pro Group	$610K	178.42	-$14.32M	-$0.71	N/A
OrthoPediatrics	$236.35M	1.98	-$39.65M	-$1.68	N/A

OrthoPediatrics has a net margin of -16.31% compared to Safe Pro Group's net margin of -800.91%. OrthoPediatrics' return on equity of -7.01% beat Safe Pro Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Safe Pro Group	-800.91%	-119.17%	-107.17%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

69.1% of OrthoPediatrics shares are held by institutional investors. 54.8% of Safe Pro Group shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Safe Pro Group presently has a consensus target price of $10.00, indicating a potential upside of 91.94%. OrthoPediatrics has a consensus target price of $24.44, indicating a potential upside of 34.35%. Given Safe Pro Group's higher probable upside, analysts clearly believe Safe Pro Group is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Safe Pro Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.80
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Summary

Safe Pro Group beats OrthoPediatrics on 9 of the 17 factors compared between the two stocks.

How does Safe Pro Group compare to ClearPoint Neuro?

ClearPoint Neuro (NASDAQ:CLPT) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, valuation, institutional ownership, dividends, risk and earnings.

Safe Pro Group has lower revenue, but higher earnings than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ClearPoint Neuro	$36.97M	11.08	-$25.54M	-$1.01	N/A
Safe Pro Group	$610K	178.42	-$14.32M	-$0.71	N/A

30.1% of ClearPoint Neuro shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Comparatively, 54.8% of Safe Pro Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Safe Pro Group had 8 more articles in the media than ClearPoint Neuro. MarketBeat recorded 9 mentions for Safe Pro Group and 1 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.87 beat Safe Pro Group's score of 0.43 indicating that ClearPoint Neuro is being referred to more favorably in the media.

Company	Overall Sentiment
ClearPoint Neuro	Very Positive
Safe Pro Group	Neutral

ClearPoint Neuro has a net margin of -71.57% compared to Safe Pro Group's net margin of -800.91%. Safe Pro Group's return on equity of -119.17% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ClearPoint Neuro	-71.57%	-140.96%	-36.98%
Safe Pro Group	-800.91%	-119.17%	-107.17%

ClearPoint Neuro currently has a consensus target price of $18.00, suggesting a potential upside of 31.74%. Safe Pro Group has a consensus target price of $10.00, suggesting a potential upside of 91.94%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts clearly believe Safe Pro Group is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Safe Pro Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.80

ClearPoint Neuro has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3.28, suggesting that its stock price is 228% more volatile than the broader market.

Summary

Safe Pro Group beats ClearPoint Neuro on 11 of the 17 factors compared between the two stocks.

How does Safe Pro Group compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability.

Delcath Systems presently has a consensus price target of $22.50, indicating a potential upside of 87.58%. Safe Pro Group has a consensus price target of $10.00, indicating a potential upside of 91.94%. Given Safe Pro Group's stronger consensus rating and higher possible upside, analysts clearly believe Safe Pro Group is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Safe Pro Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.80

Delcath Systems has higher revenue and earnings than Safe Pro Group. Safe Pro Group is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.86	$2.70M	$0.01	1,199.50
Safe Pro Group	$610K	178.42	-$14.32M	-$0.71	N/A

Delcath Systems has a net margin of 0.62% compared to Safe Pro Group's net margin of -800.91%. Delcath Systems' return on equity of 0.51% beat Safe Pro Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Safe Pro Group	-800.91%	-119.17%	-107.17%

Delcath Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Safe Pro Group has a beta of 3.28, meaning that its stock price is 228% more volatile than the broader market.

61.1% of Delcath Systems shares are held by institutional investors. 19.4% of Delcath Systems shares are held by company insiders. Comparatively, 54.8% of Safe Pro Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Safe Pro Group had 7 more articles in the media than Delcath Systems. MarketBeat recorded 9 mentions for Safe Pro Group and 2 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.94 beat Safe Pro Group's score of 0.43 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Delcath Systems	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Safe Pro Group	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Delcath Systems beats Safe Pro Group on 10 of the 17 factors compared between the two stocks.

How does Safe Pro Group compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends.

Conexeu Sciences has higher earnings, but lower revenue than Safe Pro Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Safe Pro Group	$610K	178.42	-$14.32M	-$0.71	N/A

In the previous week, Safe Pro Group had 6 more articles in the media than Conexeu Sciences. MarketBeat recorded 9 mentions for Safe Pro Group and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.44 beat Safe Pro Group's score of 0.43 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Safe Pro Group	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral

Safe Pro Group has a consensus price target of $10.00, indicating a potential upside of 91.94%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts plainly believe Safe Pro Group is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Safe Pro Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.80

Conexeu Sciences has a net margin of 0.00% compared to Safe Pro Group's net margin of -800.91%. Conexeu Sciences' return on equity of 0.00% beat Safe Pro Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Safe Pro Group	-800.91%	-119.17%	-107.17%

Summary

Safe Pro Group beats Conexeu Sciences on 6 of the 10 factors compared between the two stocks.

How does Safe Pro Group compare to CapsoVision?

Safe Pro Group (NASDAQ:SPAI) and CapsoVision (NASDAQ:CV) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

CapsoVision has a net margin of -198.87% compared to Safe Pro Group's net margin of -800.91%. CapsoVision's return on equity of 0.00% beat Safe Pro Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Safe Pro Group	-800.91%	-119.17%	-107.17%
CapsoVision	-198.87%	N/A	-136.03%

Safe Pro Group presently has a consensus target price of $10.00, suggesting a potential upside of 91.94%. CapsoVision has a consensus target price of $8.50, suggesting a potential upside of 18.06%. Given Safe Pro Group's stronger consensus rating and higher possible upside, research analysts clearly believe Safe Pro Group is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Safe Pro Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	2 Strong Buy rating(s)	2.80
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

Safe Pro Group has higher earnings, but lower revenue than CapsoVision. Safe Pro Group is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Safe Pro Group	$610K	178.42	-$14.32M	-$0.71	N/A
CapsoVision	$13.55M	26.55	-$25.32M	-$2.34	N/A

In the previous week, Safe Pro Group had 7 more articles in the media than CapsoVision. MarketBeat recorded 9 mentions for Safe Pro Group and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.32 beat Safe Pro Group's score of 0.43 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Safe Pro Group	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	2 Very Negative mention(s)	Neutral
CapsoVision	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Safe Pro Group beats CapsoVision on 8 of the 13 factors compared between the two stocks.

Get Safe Pro Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SPAI vs. The Competition

Export

Metric	Safe Pro Group	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$108.82M	$4.47B	$6.76B	$12.37B
Dividend Yield	N/A	2.12%	3.11%	5.66%
P/E Ratio	-7.34	45.65	29.53	24.71
Price / Sales	178.42	51.14	402.07	165.59
Price / Cash	N/A	39.11	23.11	37.92
Price / Book	6.20	4.76	5.79	6.85
Net Income	-$14.32M	$31.79M	$203.78M	$337.45M
7 Day Performance	-7.62%	1.77%	1.55%	2.70%
1 Month Performance	19.77%	1.32%	3.25%	4.60%
1 Year Performance	73.09%	30.37%	38.09%	32.81%

Safe Pro Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SPAI Safe Pro Group	3.6417 of 5 stars	$5.21 +1.8%	$10.00 +91.9%	+70.1%	$108.82M	$610K	N/A	11	Gap Up
KIDS OrthoPediatrics	3.0394 of 5 stars	$18.49 +1.4%	$24.44 +32.2%	-15.8%	$468.24M	$236.35M	N/A	200	Analyst Forecast
CLPT ClearPoint Neuro	2.637 of 5 stars	$13.59 +1.6%	$18.00 +32.5%	+16.5%	$401.26M	$36.97M	N/A	110	Gap Up
DCTH Delcath Systems	2.7667 of 5 stars	$11.69 +6.9%	$22.50 +92.5%	-23.6%	$377.67M	$85.23M	1,169.00	60	Gap Up High Trading Volume
CNXU Conexeu Sciences	N/A	$13.94 -8.7%	N/A	N/A	$352.26M	N/A	N/A	4	Short Interest Increase Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SPAI) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Safe Pro Group (SPAI) Competitors

SPAI vs. KIDS, CLPT, DCTH, CNXU, and CV

How does Safe Pro Group compare to OrthoPediatrics?

Summary

How does Safe Pro Group compare to ClearPoint Neuro?

Summary

How does Safe Pro Group compare to Delcath Systems?

Summary

How does Safe Pro Group compare to Conexeu Sciences?

Summary

How does Safe Pro Group compare to CapsoVision?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPAI vs. The Competition

Safe Pro Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Safe Pro Group (SPAI) Competitors

SPAI vs. KIDS, CLPT, DCTH, CNXU, and CV

How does Safe Pro Group compare to OrthoPediatrics?

Which has more risk & volatility, SPAI or KIDS?

Does the media refer more to SPAI or KIDS?

Which has higher valuation and earnings, SPAI or KIDS?

Is SPAI or KIDS more profitable?

Do institutionals and insiders have more ownership in SPAI or KIDS?

Do analysts rate SPAI or KIDS?

Summary

How does Safe Pro Group compare to ClearPoint Neuro?

Which has stronger valuation and earnings, CLPT or SPAI?

Do institutionals & insiders hold more shares of CLPT or SPAI?

Does the media refer more to CLPT or SPAI?

Is CLPT or SPAI more profitable?

Do analysts recommend CLPT or SPAI?

Which has more risk and volatility, CLPT or SPAI?

Summary

How does Safe Pro Group compare to Delcath Systems?

Do analysts rate DCTH or SPAI?

Which has higher valuation & earnings, DCTH or SPAI?

Is DCTH or SPAI more profitable?

Which has more risk & volatility, DCTH or SPAI?

Do institutionals & insiders believe in DCTH or SPAI?

Does the media refer more to DCTH or SPAI?

Summary

How does Safe Pro Group compare to Conexeu Sciences?

Which has better earnings and valuation, CNXU or SPAI?

Does the media prefer CNXU or SPAI?

Do analysts recommend CNXU or SPAI?

Is CNXU or SPAI more profitable?

Summary

How does Safe Pro Group compare to CapsoVision?

Is SPAI or CV more profitable?

Do analysts rate SPAI or CV?

Which has preferable earnings and valuation, SPAI or CV?

Does the media prefer SPAI or CV?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SPAI vs. The Competition

Safe Pro Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools